Global Stem Cell Banking Market worth USD 9.87 Billion by 2024

Global Stem Cell Banking Market worth USD 9.87 Billion by 2024

Pune, India, January 23, 2019 -- /360iResearch/ -- The report "Global Stem Cell Banking Market - Premium Insight, Industry Trends, FPNV Positioning Matrix, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2024 (Q4 2018 Update)", published by 360iResearch, states that the global market was valued at USD 5.68 billion in 2017 and is projected to reach USD 9.87 billion by 2024, growing at a CAGR of 8.21% from 2017 to 2024.

The major forces driving the growth of the stem cell banking market include the rising awareness of the therapeutic potential of stem cells and technology development related to stem cell preservation, storage, and processing. Moreover, advance hematopoietic stem cell transplantation procedures and investment friendly stem cell-based research are also some of the factors that are driving the market growth. However limited affordability of stem cell banking, and stringent regulatory frameworks may hinder the market growth. In the middle of difficulty lies opportunity such as the increasing demand and potential from emerging countries. The possible challenges for the market growth is socio-ethical concerns related to embryonic stem cells. But key players in the market are overcoming the challenges with continual improvement and innovation.

Based on service, the global stem cell banking market is studied across Analysis, Collection, Processing, Storage, and Transportation. Based on source, the global stem cell banking market is studied across Adipose Tissue-Derived Stem Cells, Bone Marrow-Derived Stem Cells, Dental Pulp-Derived Stem Cells, Human Embryo-Derived Stem Cells, and Placental Stem Cells. Based on type, the global stem cell banking market is studied across Cord Blood, and Cord Tissue. Based on application, the global stem cell banking market is studied across Clinical Research, and Personalized Banking. Based on geography, the global stem cell banking market is studied across Americas, Europe, Middle East & Africa, and Asia-Pacific.

The report features a competitive scenario of the stem cell banking market and provides inclusive analysis of key growth strategies adopted by major players. Key company profiled in the study are Amag Pharmaceuticals, Inc., Americord Registry LLC, China Cord Blood Corporation, Cord Blood America, Inc., Cord Blood Registry Systems, CordVida, Cordlife, Cordlife Group Limited, Cryo-Cell International, Cryo-Cell International, Inc., Cryo-Save AG, Cryoholdco De LatinoAmerica, S.A.P.I. DE C.V., Global Cord Blood, LifeCell International, Lifeforce Cryobank Sciences, Inc., Smart Cells International, StemCyte, ViaCord, and Vita34.

About 360iResearch

360iResearch LLP, headquartered in Pune, India, is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as Aerospace & Defense, Agriculture, Automotive & Transportation, Building, Construction & Real Estate, Chemicals & Advanced Material, Consumer Goods & Retail, Energy & Utilities, Food & Beverage, Healthcare & Life Sciences, Information Technology, Packaging, and Semiconductor & Electronics.

Contact:
Miss. Shikha Sachan
Business Lead,
Nyati Elan,
Wagholi, Pune,
Maharashtra,
India - 412207.
USA: +1-530-264-8485
India: +91-9075017818
Email: [email protected]